Mpm Bioventures 2018, L.p. - Net Worth and Insider Trading
Mpm Bioventures 2018, L.p. Net Worth
The estimated net worth of Mpm Bioventures 2018, L.p. is at least $221 Million dollars as of 2024-09-20. Mpm Bioventures 2018, L.p. is the 10% Owner of ITeos Therapeutics Inc and owns about 13,822,380 shares of ITeos Therapeutics Inc (ITOS) stock worth over $155 Million. Mpm Bioventures 2018, L.p. is also the 10% Owner of Entrada Therapeutics Inc and owns about 4,425,784 shares of Entrada Therapeutics Inc (TRDA) stock worth over $66 Million. Details can be seen in Mpm Bioventures 2018, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mpm Bioventures 2018, L.p. has not made any transactions after 2022-01-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mpm Bioventures 2018, L.p.
Mpm Bioventures 2018, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mpm Bioventures 2018, L.p. owns 3 companies in total, including Dyne Therapeutics Inc (DYN) , ITeos Therapeutics Inc (ITOS) , and Entrada Therapeutics Inc (TRDA) .
Click here to see the complete history of Mpm Bioventures 2018, L.p.’s form 4 insider trades.
Insider Ownership Summary of Mpm Bioventures 2018, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| DYN | Dyne Therapeutics Inc | 2020-09-16 | 10 percent owner |
| ITOS | ITeos Therapeutics Inc | 2022-01-05 | 10 percent owner |
| TRDA | Entrada Therapeutics Inc | 2021-11-02 | 10 percent owner |
Mpm Bioventures 2018, L.p. Latest Holdings Summary
Mpm Bioventures 2018, L.p. currently owns a total of 2 stocks. Among these stocks, Mpm Bioventures 2018, L.p. owns 13,822,380 shares of ITeos Therapeutics Inc (ITOS) as of January 5, 2022, with a value of $155 Million and a weighting of 70.01%. Mpm Bioventures 2018, L.p. also owns 4,425,784 shares of Entrada Therapeutics Inc (TRDA) as of November 2, 2021, with a value of $66 Million and a weighting of 29.99%.
Latest Holdings of Mpm Bioventures 2018, L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ITOS | ITeos Therapeutics Inc | 2022-01-05 | 13,822,380 | 11.21 | 154,948,880 |
| TRDA | Entrada Therapeutics Inc | 2021-11-02 | 4,425,784 | 15.00 | 66,386,760 |
Holding Weightings of Mpm Bioventures 2018, L.p.
Mpm Bioventures 2018, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Mpm Bioventures 2018, L.p. has made a total of 18 transactions in ITeos Therapeutics Inc (ITOS) over the past 5 years, including 0 buys and 18 sells. The most-recent trade in ITeos Therapeutics Inc is the sale of 146,685 shares on January 5, 2022, which brought Mpm Bioventures 2018, L.p. around $6 Million.
According to the SEC Form 4 filings, Mpm Bioventures 2018, L.p. has made a total of 1 transactions in Entrada Therapeutics Inc (TRDA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Entrada Therapeutics Inc is the acquisition of 100,000 shares on November 2, 2021, which cost Mpm Bioventures 2018, L.p. around $2 Million.
Insider Trading History of Mpm Bioventures 2018, L.p.
- 1
Mpm Bioventures 2018, L.p. Trading Performance
GuruFocus tracks the stock performance after each of Mpm Bioventures 2018, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mpm Bioventures 2018, L.p. is -63.03%. GuruFocus also compares Mpm Bioventures 2018, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Mpm Bioventures 2018, L.p. within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mpm Bioventures 2018, L.p.'s insider trading performs compared to the benchmark.
Performance of Mpm Bioventures 2018, L.p.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 13.7 | | | | | |
| Relative Return to S&P 500(%) | 14.86 | | | | | |
Mpm Bioventures 2018, L.p. Ownership Network
Mpm Bioventures 2018, L.p. Owned Company Details
What does Dyne Therapeutics Inc do?
Who are the key executives at Dyne Therapeutics Inc?
Mpm Bioventures 2018, L.p. is the 10 percent owner of Dyne Therapeutics Inc. Other key executives at Dyne Therapeutics Inc include See Remarks Richard William Scalzo , Chief Operating Officer Susanna Gatti High , and See Remarks Oxana Beskrovnaya .
Dyne Therapeutics Inc (DYN) Insider Trades Summary
Over the past 18 months, Mpm Bioventures 2018, L.p. made no insider transaction in Dyne Therapeutics Inc (DYN). Other recent insider transactions involving Dyne Therapeutics Inc (DYN) include a net sale of 327,516 shares made by Richard William Scalzo , a net sale of 273,683 shares made by Susanna Gatti High , and a net sale of 140,498 shares made by Oxana Beskrovnaya .
In summary, during the past 3 months, insiders sold 2,080,955 shares of Dyne Therapeutics Inc (DYN) in total and bought 32,000 shares, with a net sale of 2,048,955 shares. During the past 18 months, 7,664,687 shares of Dyne Therapeutics Inc (DYN) were sold and 1,746,285 shares were bought by its insiders, resulting in a net sale of 5,918,402 shares.
Dyne Therapeutics Inc (DYN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Dyne Therapeutics Inc Insider Transactions
Mpm Bioventures 2018, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Mpm Bioventures 2018, L.p.. You might contact Mpm Bioventures 2018, L.p. via mailing address: 450 Kendall Street, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
